Emerald Clinical Trials Announces Leadership Change and Business Continuity Plans Emerald Clinical Trials has confirmed the appointment of Glenn Kerkhof as interim CEO following Mary Gunn's resignation, ensuring business continuity.

Emerald Clinical Trials Announces Leadership Change and Business Continuity Plans #Singapore #Emerald_Clinical_Trials #Glenn_Kerkhof #Mary_Gunn

Emerald Clinical Trials Announces CEO Transition and Succession Planning Strategy Emerald Clinical Trials has announced a significant leadership change, appointing Glenn Kerkhof as interim CEO following Mary Gunn's departure, ensuring operational stability.

Emerald Clinical Trials Announces CEO Transition and Succession Planning Strategy #USA #Singapore #Emerald_Clinical_Trials #Glenn_Kerkhof #Mary_Gunn

Emerald Clinical Trials Announces Leadership Transition and Continuity Plan Emerald Clinical Trials has confirmed a key leadership transition, appointing Glenn Kerkhof as interim CEO to ensure operational continuity and stability.

Emerald Clinical Trials Announces Leadership Transition and Continuity Plan #USA #Singapore #Emerald_Clinical #Glenn_Kerkhof #Mary_Gunn

Emerald Clinical Trials Announces Leadership Change and Continuity Plan Amid Transition Emerald Clinical Trials has confirmed a leadership change as Mary Gunn steps down. Glenn Kerkhof will serve as interim CEO while a permanent replacement is sought.

Emerald Clinical Trials Announces Leadership Change and Continuity Plan Amid Transition #USA #Singapore #Emerald_Clinical_Trials #Glenn_Kerkhof #Mary_Gunn

Emerald Clinical Trials Announces Leadership Change and Transition Plan for New CEO Emerald Clinical Trials has confirmed a leadership transition with Glenn Kerkhof appointed as interim CEO, following Mary Gunn's resignation.

Emerald Clinical Trials Announces Leadership Change and Transition Plan for New CEO #Singapore #Emerald_Clinical #Glenn_Kerkhof #Mary_Gunn

Emerald Clinical Trials Appoints New Interim CEO Amid Leadership Transition Emerald Clinical Trials announces a leadership change, appointing Glenn Kerkhof as interim CEO following Mary Gunn's departure, ensuring continuity.

Emerald Clinical Trials Appoints New Interim CEO Amid Leadership Transition #USA #Singapore #Emerald_Clinical #Glenn_Kerkhof #Mary_Gunn

Emerald Clinical Trials Announces Leadership Transition and Continuity Plan Amidst Changes Emerald Clinical Trials has confirmed the transition of leadership with the appointment of Glenn Kerkhof as interim CEO following Mary Gunn's departure.

Emerald Clinical Trials Announces Leadership Transition and Continuity Plan Amidst Changes #USA #Singapore #Emerald_Clinical_Trials #Glenn_Kerkhof #Mary_Gunn

Emerald Clinical Trials Announces Leadership Change with Glenn Kerkhof as Interim CEO Emerald Clinical Trials has announced a leadership transition with Glenn Kerkhof appointed as Interim CEO following Mary Gunn's departure.

Emerald Clinical Trials Announces Leadership Change with Glenn Kerkhof as Interim CEO #USA #Singapore #Emerald_Clinical_Trials #Glenn_Kerkhof #Mary_Gunn

Emerald Clinical Trials Announces Leadership Change and Future Strategic Plans Emerald Clinical Trials, a top global provider in clinical research, confirms a leadership transition with Glenn Kerkhof stepping in as Interim CEO, ensuring continuity.

Emerald Clinical Trials Announces Leadership Change and Future Strategic Plans #Singapore #Emerald_Clinical_Trials #Glenn_Kerkhof #Mary_Gunn